3 great stocks to buy in 2015: Slater & Gordon Limited, Credit Corp Group Limited and Challenger Ltd

Despite promising long-term growth prospects, Slater & Gordon Limited (ASX:SGH), Credit Corp Group Limited (ASX:CCP) and Challenger Ltd (ASX:CGF) trade cheap.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Do you like buying cheap stocks and are you willing to let your money work for you over many years?

If so, keep reading…

Because Slater & Gordon Limited (ASX: SGH), Credit Corp Group Limited (ASX: CCP) and Challenger Ltd (ASX: CGF) look cheap, have promising long-term growth prospects and are very well run.

Here's what you need to know…

Slater & Gordon is Australia's leading personal injury law firm (with around 25% market share) but is also growing quickly in the larger UK market, where its share is estimated at just 5%. The targeted market is five times larger than ours and highly fragmented. With expanding margins and growth opportunities locally and aboard, now could be a great time to buy shares in this top growth stock.

Credit Corp is a leading receivables management company whose shares trade cheap and offer investors a solid 4.6% fully franked dividend. Since falling hard in the depths of the GFC, the company has bounced back, climbing 235%. The company boasts some useful countercyclical features and offers growth potential in the form of an expanding short-term consumer loan book and entrance into the US market.

Finally Challenger is Australia's largest provider of annuities to retirees. An annuity offers guaranteed returns to investors for an upfront lump sum payment, which is invested by Challenger out over many years. The company is uniquely placed to benefit from both a bulging superannuation pool and the retirement of the baby boomer population. It also has a growing funds management division.

Despite the obvious long-term tailwinds, Challenger shares trade cheap and offer a handsome 4.7% fully franked dividend. Due to the nature of Challenger's business, it is heavily regulated. Whilst this can be troublesome at times, it provides some certainty for shareholders and clients, whilst also creating barriers to entry.

Motley Fool Contributor Owen Raszkiewicz owns shares of Slater & Gordon. You can follow Owen on Twitter @ASXinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »